伐尼克兰

信号通路 >> 跨膜转运 >> 胆碱受体

信号通路 >> 神经信号通路 >> 胆碱受体

研究领域 >> 神经疾病

[1]. Kikkawa, H.; Maruyama, N.; Fujimoto, Y.; Hasunuma, T. Single- and multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy Japanese adult smokers. Journal of Clinical Pharmacology (2011), 51(4), 527-537.

[2]. Bordia T, Hrachova M, Chin M et al. Varenicline Is a Potent Partial Agonist at α6β2* Nicotinic Acetylcholine Receptors in Rat and Monkey Striatum. J Pharmacol Exp Ther. 2012 Aug;342(2):327-34.

[3]. Pachas GN, Cather C, Pratt SA et al. Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week, Open-Label Trial. J Dual Diagn. 2012;8(2):117-125.

[4]. Krebs P, Sherman SE. Review: Varenicline for tobacco cessation does not increase CV serious adverse events. Ann Intern Med. 2012 Aug 21;157(4):JC2-2.

PNU-282987 | 卡巴胆碱 | GTS-21二盐酸盐(DMBX-A) | 柠檬酸柠康碱(MLA) | Monepantel | 六甲溴铵 | N-(5-氯-2,4-二甲氧基苯基)-N’-(5-甲基-3-异唑基)脲 | 盐酸甲氯芬酯 | ZSET1446 | 阿尼西坦 | Desformylflustrabromine hydrochloride | Encenicline hydrochloride | 盐酸洛贝林 | Tebanicline hydrochloride | 长春质碱